Preoperative White Blood Cell Count and Mortality and Morbidity After Coronary Artery Bypass Grafting
|
|
- Oliver Griffin
- 6 years ago
- Views:
Transcription
1 Preoperative White Blood Cell Count and Mortality and Morbidity After Coronary Artery Bypass Grafting Lawrence J. Dacey, MD, Joseph DeSimone, MD, John H. Braxton, MD, Bruce J. Leavitt, MD, Stephen J. Lahey, MD, John D. Klemperer, MD, Benjamin M. Westbrook, MD, Elaine M. Olmstead, and Gerald T. O Connor, PhD, DSc, for the Northern New England Cardiovascular Disease Study Group Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Department of Surgery, Maine Medical Center, Portland, Maine; Department of Surgery, Fletcher-Allen Health Care, Burlington, Vermont; Department of Surgery, Beth Israel-Deaconess Medical Center, Boston, Massachusetts; Department of Surgery, Eastern Maine Medical Center, Bangor, Maine; Department of Surgery, Catholic Medical Center, Manchester, New Hampshire; and Departments of Medicine and Community & Family Medicine and the Center for the Evaluative Clinical Sciences, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire Background. Arteriosclerosis is increasingly viewed as an inflammatory disease. The purpose of these analyses was to examine the preoperative white blood cell (WBC) count, a generalized marker of inflammation, and to assess its association with in-hospital mortality and other adverse outcomes after coronary artery bypass grafting. Methods. Information was collected prospectively on 11,270 consecutive patients who had isolated coronary artery bypass grafting in northern New England from 1996 through Patients were divided into five categories based on their preoperative WBC count. Crude and adjusted in-hospital mortality rates and adverse event rates were calculated using logistic regression. Results. Increasing WBC count across its entire range was associated with a linear increase in the mortality rate. This finding was highly significant (p [trend] < 0.001) and persisted after adjustment for patient and disease characteristics. Patients with preoperative WBC of at least /L had an adjusted mortality rate 2.8 times higher than those with a WBC less than /L (4.8% versus 1.7%). An increasing preoperative WBC count was also significantly associated with increasing rates of perioperative strokes and the need for an intraaortic balloon pump but was not associated with mediastinitis. Conclusions. The preoperative WBC count across its entire observed range is a statistically significant independent predictor of in-hospital death and other adverse outcomes after coronary artery bypass grafting. Although the cause of the association between increased WBC count and increased morbidity and mortality is unknown, the preoperative WBC count, which is objectively measured, inexpensive, and always available, can serve as a useful marker to help predict risk before coronary artery bypass grafting. (Ann Thorac Surg 2003;76:760 4) 2003 by The Society of Thoracic Surgeons Arteriosclerosis is increasingly viewed as an inflammatory disease [1]. Markers of inflammation, both generalized and specific, can be used to predict the risk of cardiovascular events [2 4]. The baseline white blood cell (WBC) count, a generalized marker of inflammation, has been correlated positively with the development of coronary artery disease and the risk of future acute myocardial infarction. Studies have shown that the risk of acute myocardial infarction is two to four times as great in patients with WBC counts in the high normal range (9.0 to /L) compared with patients with WBC counts in the low normal range (4.0 to /L). Accepted for publication April 3, Address reprint requests to Dr Dacey, Cardiothoracic Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH ; lawrence.j.dacey@dartmouth.edu. After acute myocardial infarction, an increased WBC count on admission has been shown to be predictive of the development of congestive heart failure and death [5]. However, to date the association between the WBC count and adverse outcomes after coronary artery bypass has not been examined closely. The purpose of this study was to examine the preoperative WBC count and to assess its association with in-hospital death and other adverse outcomes after coronary artery bypass. Material and Methods Patients and Setting The Northern New England Cardiovascular Disease Study Group is a voluntary research consortium representing all medical centers in Maine, New Hampshire, and Vermont where coronary artery bypass grafting (CABG) is performed, along with the Beth Israel Deacon by The Society of Thoracic Surgeons /03/$30.00 Published by Elsevier Inc PII S (03)
2 Ann Thorac Surg DACEY ET AL 2003;76:760 4 PREOPERATIVE WBC AND CABG ess Medical Center (Boston, MA). Since 1987, the Northern New England Cardiovascular Disease Study Group has maintained a prospective registry of all patients who have cardiac operations in the region. This is a multicenter study of 11,270 consecutive patients who had isolated CABG between 1996 and 2000 in northern New England. The internal review boards of the participating institutions approved this study. Risk Factors All patients had been prospectively entered into a data registry, which records patient characteristics, processes of care, and outcomes. From the registry the following data were available: patient age, gender, height, and weight; baseline laboratory studies, including blood chemistries and hematology; comorbid conditions; degree of left main coronary artery stenosis; total number of significantly diseased vessels; ejection fraction; recent myocardial infarction; prior CABG or percutaneous transluminal coronary angioplasty; and operative priority (elective or urgent/emergent). Complete definitions of these variables have been published previously [6]. The WBC count used in these analyses was the last one recorded preoperatively and was performed at various times preoperatively. Mortality and Adverse Outcomes The registry also contained information on the intraoperative or postoperative uses of intraaortic balloon pump, the development of stroke or mediastinitis, and mortality status at discharge from the hospital. Stroke was defined as a new fixed neurologic deficit lasting more than 24 hours. Mediastinitis was defined as the presence of two or more of the following findings in the absence of another recognized cause during the initial hospitalization: 1) organisms and WBCs seen on Gram stain in aspirated fluid, 2) positive results of deep wound culture, 3) radiographic evidence of infection, or 4) sternal dehiscence requiring reoperation. Analysis Patients were divided into five categories based on their preoperative WBC count ( 10 9 /L) as follows: less than 6.0, 6.0 to 7.9, 8.0 to 9.9, 10.0 to 11.9, and 12.0 or more. Mortality rates and rates of other adverse outcomes were determined for each of the five WBC count categories. Baseline patient and disease characteristics were summarized by means for the continuous variables and by percentages for the discrete variables. Nonparametric tests for trend were performed across the WBC count groups, which were treated as ordinal variables. To adjust for confounding variables, we used multivariate logistic regression and direct standardization techniques. Variables that differed significantly among groups, as well as common known risk factors for morbidity and mortality after CABG, were selected for multivariate analysis. All statistical analyses were conducted using the STATA 6.0 statistical program (Stata Corp, College Station, TX) [7]. 761 Results Patient Characteristics The preoperative WBC count ranged from 0.7 to /L, with a mean value of /L. Eighty-three percent of patients had white cell counts of less than /L (18% had /L, 38% had 6.0 to /L, and 27% had 8.0 to /L). Eleven percent of patients had values in the 10 to /L range, and 6% had values of /L or above. Patient and disease characteristics stratified by preoperative WBC counts are shown in Table 1. Patients with increasing WBC counts were slightly younger, more likely to be women, more obese, and had more comorbid conditions, including peripheral vascular disease, diabetes, chronic obstructive pulmonary disease, congestive heart failure, and renal failure. Patients with higher WBC counts also had poorer ventricular function, higher left ventricular end-diastolic pressure, more extensive coronary disease, were more likely to have had a recent myocardial infarction, and were more often in the urgent or emergent operative categories (p [trend] for all variables). There was not a significant association seen with increasing WBC count and the presence of unstable angina (p [trend] 0.058). Mortality There were 294 deaths in this group of 11,270 patients for an overall mortality rate of 2.61%. Crude mortality rates ranged from 1.40% among those with WBC count less than /L, to 7.12% among those in the highest WBC category (Fig 1). After adjusting for age, sex, body mass index, peripheral vascular disease, diabetes, chronic obstructive pulmonary disease, renal failure, congestive heart failure, ejection fraction, left ventricular enddiastolic pressure, left main disease, prior CABG or percutaneous transluminal coronary angioplasty, recent myocardial infarction, number of diseased vessels, and priority, the preoperative WBC count remained a highly significant and strong predictor of in-hospital death after CABG (Table 2). The adjusted mortality rate was 1.7% for those in the lowest WBC group and increased steadily and nearly linearly across categories to 4.8%, or 2.8 times higher, for those in the highest WBC group (p [trend] 0.001). This association of increasing WBC count and mortality rate was evident even within the normal range of the WBC count. Patients in the high normal range of WBC count (8 to /L) had a mortality rate 61% higher (2.8% versus 1.7%) than those in the low normal range ( /L). When analyzed as a continuous variable, WBC count was associated with a statistically significant (p 0.001) 13% relative increase in death per /L increase. Other Adverse Outcomes Higher WBC count was significantly associated with increased rates of perioperative stroke and the need for a postoperative intraaortic balloon pump. There was approximately a 75% higher adjusted rate of stroke from the CARDIOVASCULAR
3 762 DACEY ET AL Ann Thorac Surg PREOPERATIVE WBC AND CABG 2003;76:760 4 Table 1. Patient and Disease Characteristics by Preoperative White Blood Cell Count Variable WBC Category p Trend Number of procedures Age, (years) mean Sex, % female Mean body surface area (m 2 ) Body mass index (%) (%) Comorbid disease PVD, % yes DM, % yes COPD, % yes CHF, % yes RF, % yes Ejection fraction, mean Ejection fraction 40, % yes Mean LVEDP Coronary artery disease Left main 50, % yes Unstable angina, % yes No. of diseased vessels, mean Prior PTCA, % yes Prior CABG, % yes Recent MI ( 7 days), % yes Urgent/emergent operative status, % yes CABG coronary artery bypass grafting; CHF congestive heart failure; COPD chronic obstructive pulmonary disease; DM diabetes; LM left main disease; LVEDP left ventricular end diastolic pressure; MI myocardial infarction; PTCA percutaneous transluminal coronary angioplasty; PVD peripheral vascular disease; RF renal failure; UA unstable angina; WBC white blood cell. lowest to the highest WBC category (1.2% versus 2.1%, p [trend] 0.003). Likewise, the adjusted rate of insertion of a postoperative intraaortic balloon pump was more than twice as high among patients in the high WBC category compared with patients in the lowest WBC category (4.6% versus 2.2%, p [trend] 0.001). There was no statistically significant association between increasing Fig 1. Crude (diamonds) and adjusted (circles) in-hospital mortality rates by preoperative white blood cell (WBC) category. WBC count and adjusted rates of mediastinitis (range 0.9% to 1.5%, p[trend] 0.25). Comment In this study, the preoperative WBC count was a statistically significant and strong predictor of in-hospital death and other adverse events after CABG. There was a nearly linear monotonic increase in the adjusted mortality rates seen with increasing baseline WBC count. Patients with a WBC count of at least /L had an adjusted mortality rate 2.8 times as high as those with a WBC count less than /L. This is an increased risk similar to dialysis-dependent renal failure or a prior CABG. Patients with a WBC count in the high normal range had an adjusted mortality rate 61% higher than those with a WBC count in the low normal range. This risk is roughly equivalent to the risk associated with peripheral vascular disease or congestive heart failure. Similarly, the adjusted rate of a perioperative stroke or requirement for an intraoperative or postoperative intraaortic balloon pump increased significantly as the preoperative WBC count increased, doubling from the lowest to highest categories. Arteriosclerosis is increasingly viewed as a chronic inflammatory disease. An association between a baseline
4 Ann Thorac Surg DACEY ET AL 2003;76:760 4 PREOPERATIVE WBC AND CABG Table 2. Adjusted a Rates of Adverse Outcomes by Preoperative White Blood Cell Count Adverse Outcome WBC Category p Trend CARDIOVASCULAR In-hospital mortality (%) Perioperative stroke (%) Intra- or postoperative IABP (%) Mediastinitis (%) a Rates adjusted for age, sex, body mass index, peripheral vascular disease, diabetes, chronic obstructive pulmonary disease, preoperative renal failure, preoperative congestive heart failure, preoperative ejection fraction, preoperative left ventricular end-diastolic pressure, left main coronary artery stenosis 50%, prior coronary artery bypass grafting or percutaneous transluminal coronary angioplasty, recent myocardial infarction, number of diseased vessels and operative priority. IABP intraaortic balloon pump. WBC count and risk of coronary heart disease has been demonstrated consistently in epidemiologic studies and includes both fatal and nonfatal events [8 13]. In general, the risk of developing coronary heart disease is two times higher in patients with WBC counts of 8 to /L compared with patients with counts of 4 to /L. This twofold difference is similar to the relative risk of standard risk factors, such as serum cholesterol, hypertension, and cigarette smoking. The relationship appears to be a dose-response effect, with higher WBC counts associated with graded increases in risk of coronary heart disease. Additionally, one study showed that a decrease in the WBC count was associated with a decrease in risk of coronary heart disease [14]. Increasing WBC count on admission to the hospital for acute myocardial infarction has been shown to be strongly predictive of later congestive heart failure and death [15 17]. The cause of the association between a higher WBC count and a higher risk of adverse outcomes is not known. It is not known whether increasing numbers of WBCs are directly responsible for increasing injury or whether the increasing WBC count may serve only as a marker of an underlying inflammatory state. White blood cells, particularly neutrophils and macrophages, have been studied extensively in myocardial reperfusion injury and are known to have deleterious effects on myocardial cells [18]. Neutrophils accumulate in ischemic and reperfused myocardium and may participate directly in myocardial injury by the forming aggregates that alter the rheologic properties of blood in the microvasculature and by the release of activated substances, including oxygen free radicals, proteases, and proinflammatory cytokines [19]. There is an ever-increasing number of inflammatory markers, including C-reactive protein, interleukin-6, and tumor necrosis factor-alpha whose levels are predictive of risk of cardiovascular events [20 27]. The preoperative WBC count may merely serve as one of these markers of risk, with higher numbers reflective of an underlying increasingly inflammatory state. Knowledge of patients at increased risk due to an underlying heightened inflammatory state could lead to targeted therapies to help ameliorate the inflammatory response. Study Limitations There are several limitations of this study. First, we have only the total WBC count, and not the cell differential, for these patients. Neutrophils and monocytes are the WBCs most commonly implicated with inflammation. The absolute number of these cells may have contributed important information. The WBC count was collected at varying times preoperatively, depending on the patient s clinical status. We do not have information on how far in advance of operation the WBC count was measured; we know only that it was the last measurement of the WBC count preoperatively. Elective patients often had their WBC count measured weeks before their operation, whereas the WBC count from urgent and emergent patients may have been performed within hours of the operation. However, the associations between the WBC count and adverse outcomes remained strong after adjusting for surgical priority. There is also a small diurnal variation in neutrophil count in most individuals, with the highest levels in the afternoon and lowest levels in the morning at rest. Thus, a patient s WBC count could have varied depending on the time of day it was drawn. However, this variation would tend to bias the results towards the null hypothesis and underestimate the association of the WBC count and outcomes. Finally, we did not collect more specific markers of inflammation, such as C-reactive protein, interleukin-6, and TNF-alpha, which may have strengthened the association of increased risk of adverse outcomes with an increased inflammatory baseline state. The preoperative WBC count is inexpensive, objectively measured, and always available before CABG. We found the preoperative WBC count across the entire observed range to be a highly significant and strong independent predictor of in-hospital death and other adverse outcomes after CABG. Supported in part by a grant from the American Heart Association ( N). References 1. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med 1999;340: Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98: Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens
5 764 DACEY ET AL Ann Thorac Surg PREOPERATIVE WBC AND CABG 2003;76:760 4 CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336: Rader DJ. Inflammatory markers of coronary risk. N Engl J Med 2000;343: Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson M. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction. Circulation 2000; 102: O Connor GT, Plume SK, Olmstead EM, et al. A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. The Northern New England Cardiovascular Disease Study Group. JAMA 1991;266: StataCorp. Stata statistical software. Release 6.0. College Station, TX: Stata Corporation; Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290: Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol 1984;53: Lowe GD, Machado SG, Krol WF, Barton BA, Forbes CD. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost 1985;54: Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987;257: Ensrud K, Grimm RH Jr. The white blood cell count and risk for coronary heart disease. Am Heart J 1992;124: Weijenberg MP, Feskens EJ, Kromhout D. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 1996;16: Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254: Kyne L, Hausdorff JM, Knight E, Dukas L, Azhar G, Wei JY. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000;139: Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ. Effect of elevated leukocyte count on inhospital mortality following acute myocardial infarction. Am J Cardiol 1996;78: Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. Am J Cardiol 2001;87: Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 1999;43: Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation 1995;91: Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina [see comments]. N Engl J Med 1994;331: van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89: Kukielka GL, Smith CW, Manning AM, Youker KA, Michael LH, Entman ML. Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 1995;92: Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92: Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94: Liuzzo G, Baisucci LM, Gallimore JR, et al. Enhanced inflammatory response in patients with preinfarction unstable angina. J Am Coll Cardiol 1999;34: Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101: Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000;101:
Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England
ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.
More informationThe decision to discontinue aspirin preoperatively in
Effect of Preoperative Aspirin Use on Mortality in Coronary Artery Bypass Grafting Lawrence J. Dacey, MD, John J. Munoz, MD, Edward R. Johnson, MD, Bruce J. Leavitt, MD, Christopher T. Maloney, MD, Jeremy
More informationBMR Medicine. Research Article
www.bmrjournals.com Open Access Scientific Publisher Research Article RELATIONSHIP BETWEEN WHITE BLOOD CELL (WBC) COUNT AND C-REACTIVE PROTEIN (CRP) WITH ANGIOGRAPHIC SEVERITY OF CORONARY ARTERY DISEASE
More informationVariability in Surgeons Perioperative Practices May Influence the Incidence of Low-Output Failure After Coronary Artery Bypass Grafting Surgery
Variability in Surgeons Perioperative Practices May Influence the Incidence of Low-Output Failure After Coronary Artery Bypass Grafting Surgery Donald S. Likosky, PhD; Joshua B. Goldberg, MD; Anthony W.
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More informationOptimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality
ADULT CARDIAC J. MAXWELL CHAMBERLAIN MEMORIAL PAPER Optimal Timing From Myocardial Infarction to Coronary Artery Bypass Grafting on Hospital Mortality Elizabeth L. Nichols, MS, Jock N. McCullough, MD,
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationMultiple lines of evidence indicate that inflammation
Leukocyte Count as an Independent Predictor of Ischemic Events Armin J. Grau, MD; Alexander W. Boddy, MS; Deborah A. Dukovic, MS; Florian Buggle, MD; Christoph Lichy, MD; Tobias Brandt, MD; Werner Hacke,
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationPrognostic Value of C-Reactive Protein and Troponin T Level in Patients With Unstable Angina Pectoris C T KASANUKI, MD, FJCC
C T Prognostic Value of C-Reactive Protein and Troponin T Level in Patients With Unstable Angina Pectoris Hiroyuki Yukio Hiroshi TANAKA, MD TSURUMI, MD KASANUKI, MD, FJCC Abstract Objectives. The prognosis
More informationDoes the Use of Ultrafiltration Increase the Risk of Post-Operative Acute Kidney Injury? A Multi-Center Analysis
Does the Use of Ultrafiltration Increase the Risk of Post-Operative Acute Kidney Injury? A Multi-Center Analysis Gordon R. DeFoe, CCP, John Pieroni, CCP, Craig S. Warren, CCP, Charles F. Krumholz, CCP,
More informationIschemic heart disease is the leading cause of
The impact of C-Reactive Protein: A Look at the Most Recent Studies and Trials By Davinder S. Jassal, MD, FRCPC; and Blair O Neill, MD, FRCPC, FACC Ischemic heart disease is the world s leading killer,
More informationMultiple Inflammatory Prognostic Factors in Acute Coronary Syndromes: A Prospective Inception Cohort Study
ORIGINAL REPORT Multiple Inflammatory Prognostic Factors in Acute Coronary Syndromes: A Prospective Inception Cohort Study Zinat Nadia Hatmi *1, Ali Kazemi Saeid 2, Mohammad Ali Broumand 3, Shabnam Najar
More informationPatient Characteristics Can Predict Improvement in Functional Health After Elective Coronary Artery Bypass Grafting
Patient Characteristics Can Predict Improvement in Functional Health After Elective Coronary Artery Bypass Grafting Karl F. Welke, MD, Jennifer P. Stevens, MS, William C. Schults, MS, Eugene C. Nelson,
More informationCardiopulmonary Bypass Recommendations in Adults: The Northern New England Experience
The Journal of The American Society of Extra-Corporeal Technology Cardiopulmonary Bypass Recommendations in Adults: The Northern New England Experience Christian P. DioDato, CCP;* Donald S. Likosky, PhD;
More informationAppropriateness of Coronary Artery Bypass Graft Surgery Performed in Northern New England
Journal of the American College of Cardiology Vol. 51, No. 24, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.01.067
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationJournal of the American College of Cardiology Vol. 40, No. 10, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 40, No. 10, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02484-1
More informationInterventional Cardiology
Journal of the American College of Cardiology Vol. 37, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01205-5 Interventional
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationThe emergence of health maintenance organizations
Predictors of 30-Day Hospital Readmission After Coronary Artery Bypass Robert D. Stewart, MD, Christian T. Campos, MD, Beth Jennings, BA, S. Scott Lollis, BA, Sidney Levitsky, MD, and Stephen J. Lahey,
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationSince 1990, there has been a steady increase in cardiac
Outcomes of Patients Undergoing Concomitant Aortic and Mitral Valve Surgery in Northern New England Bruce J. Leavitt, MD; Yvon R. Baribeau, MD; Anthony W. DiScipio, MD; Cathy S. Ross, MS; Reed D. Quinn,
More informationMethods and result: The Prospective observational study was carried out over the period of 2 yrs where
Khatri D 1, Islam N 2, Ali A 3 1 Dr. Devendra Khatri, Consultant cardiologist, Birendra Hospital, Chhauni. 2 Prof. Nazrul Islam, Director, National Institute of Cardiovascular Diseases, Dhaka. 3 Associate
More information12 Lead EKG Chapter 4 Worksheet
Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining
More informationCoronary artery bypass graft (CABG) operations have
Variation in Hospital Rates of Intraaortic Balloon Pump Use in Coronary Artery Bypass Operations William A. Ghali, MD, MPH, Arlene S. Ash, PhD, Ruth E. Hall, MSc, and Mark A. Moskowitz, MD Health Care
More informationCoronary atherosclerotic heart disease remains the number
Twenty-Year Survival After Coronary Artery Surgery An Institutional Perspective From Emory University William S. Weintraub, MD; Stephen D. Clements, Jr, MD; L. Van-Thomas Crisco, MD; Robert A. Guyton,
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationIs bypass surgery needed for elderly patients with LMT disease? From the surgical point of view
CCT 2003 (Kobe) Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view Hitoshi Yaku, MD, PhD Department of Cardiovascular Surgery Kyoto Prefectural University of
More informationClinical Study Is Leukocytosis a Predictor for Recurrence of Ischemic Events after Coronary Artery Bypass Graft Surgery?
International Scholarly Research Network ISRN Cardiology Volume 2012, Article ID 824730, 6 pages doi:10.5402/2012/824730 Clinical Study Is Leukocytosis a Predictor for Recurrence of Ischemic Events after
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationStable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology
Stable Ischemic Heart Disease Ivan Anderson, MD RIHVH Cardiology Outline Review of the vascular biology of atherosclerosis Why not just cath everyone with angina? Medical management of ischemic cardiomyopathy
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationJournal of the American College of Cardiology Vol. 36, No. 1, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 36, No. 1, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00680-X Lack
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More informationContrast Induced Nephropathy
Contrast Induced Nephropathy O CIAKI refers to an abrupt deterioration in renal function associated with the administration of iodinated contrast media O CIAKI is characterized by an acute (within 48 hours)
More informationThe correlation of coronary artery involvement extent with white blood cell count in hospitalized patients
Available online at www.pelagiaresearchlibrary.com European Journal of Experimental Biology, 2012, 2 (1):247-252 ISSN: 2248 9215 CODEN (USA): EJEBAU The correlation of coronary artery involvement extent
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationThe Role of Unknown Risk Factors in Myocardial Infarction
Elmer Press Original Article The Role of Unknown Risk Factors in Myocardial Infarction Rafighdoust Abbas Ali a, d, Mirzaee Asadollah b, Rafigdoust Amir Hossien c Abstract Background: Atherosclerosis of
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationChanging profile of patients undergoing redo-coronary artery surgery q
European Journal of Cardio-thoracic Surgery 21 (2002) 205 211 www.elsevier.com/locate/ejcts Changing profile of patients undergoing redo-coronary artery surgery q Frans M. van Eck, Luc Noyez*, Freek W.A.
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationMEDICAL POLICY SUBJECT: TRANSMYOCARDIAL REVASCULARIZATION
MEDICAL POLICY SUBJECT: TRANSMYOCARDIAL 7/21/05, 05/18/06, 03/15/07, 02/21/08,, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply.
More informationORIGINAL ARTICLE. Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery
ORIGINAL ARTICLE Peripheral Vascular Disease and Outcomes Following Coronary Artery Bypass Graft Surgery Ted Collison, MD; J. Michael Smith, MD; Amy M. Engel, MA Hypothesis: There is an increased operative
More informationThe Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
Original Article The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Toshihiro Fukui, MD, Susumu Manabe, MD, Tomoki Shimokawa, MD,
More informationFatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins
Fatality of Future Coronary Events Is Related to Inflammation-Sensitive Plasma Proteins A Population-Based Prospective Cohort Study Gunnar Engström, MD; Bo Hedblad, MD; Lars Stavenow, MD; Patrik Tydén,
More informationCounterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece
John N. Nanas, MD, PhD Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece History of counterpulsation 1952 Augmentation of CBF Adrian and Arthur Kantrowitz, Surgery 1952;14:678-87
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationBalloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C
Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C Record Status This is a critical abstract of an economic evaluation that meets
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH
ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME: INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH AUTHORS: Marta Ponte 1, RICARDO
More informationModeling and Risk Prediction in the Current Era of Interventional Cardiology
Modeling and Risk Prediction in the Current Era of Interventional Cardiology A Report From the National Heart, Lung, and Blood Institute Dynamic Registry David R. Holmes, MD; Faith Selzer, PhD; Janet M.
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationPatient characteristics Intervention Comparison Length of followup
ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationDepartments of Cardiology, Clinical Governance, and Cardiac Surgery, The Cardiothoracic Centre-Liverpool, Liverpool, United Kingdom
Preoperative White Blood Cell Count is Independently Associated With Higher Perioperative Cardiac Enzyme Release and Increased 1-Year Mortality After Coronary Artery Bypass Grafting Nick Newall, MRCP,
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationReoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes
Original Article Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes AR Jodati, MA Yousefnia From Department of Cardiothoracic Surgery, Madani Heart Hospital, Tabriz University
More informationRisk stratification in unstable angina and non-q wave myocardial infarction using soluble cell adhesion molecules
Heart 21;85:623 627 623 Royal City of Dublin Hospital Research and Education Institute, Department of Cardiology, St James s Hospital, Dublin 8, Ireland N T Mulvihill J B Foley R T Murphy R Curtin P A
More informationManagement of Cardiogenic shock. Prof. Christian JM Vrints
Management of Cardiogenic shock Prof. Christian JM Vrints none conflicts Management of Cardiogenic Shock Incidence and trends Importance of early revascularization Multivessel disease Left main disease
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationWhite Blood Cell Count and Risk for All-Cause, Cardiovascular, and Cancer Mortality in a Cohort of Koreans
American Journal of Epidemiology Copyright ª 2005 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A. Vol. 162, No. 11 DOI: 10.1093/aje/kwi326 Advance Access publication
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationSupplementary Online Content
Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.
More informationA Comparative Evaluation of C-Reactive Protein as a Short-Term Prognostic Marker in Severe Unstable Angina A Preliminary Study
Original Article A Comparative Evaluation of C-Reactive Protein as a Short-Term Prognostic Marker in Severe Unstable Angina A Preliminary Study S Bhagat*, M Gaiha*, VK Sharma**, S Anuradha* Abstract Objective
More informationRisk Stratification Using The Society of Thoracic Surgeons Program
Risk Stratification Using The Society of Thoracic Surgeons Program Brack G. Hattler, MD, PhD, Carol Madia, PA, Carol Johnson, CRNP, John M. Armitage, MD, Robert L. Hardesty, MD, Robert L. Kormos, MD, Si
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationDifferential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction
Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy
More informationType of intervention Diagnosis. Economic study type Cost-effectiveness analysis.
The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir
More informationQuality Measures MIPS CV Specific
Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from
More informationClinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center
Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationIschaemic heart disease. IInd Chair and Clinic of Cardiology
Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationLink between effectiveness and cost data Costing was conducted prospectively on the same patient sample as that used in the effectiveness analysis.
Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention Rabah M, Mason D, Muller D W, Hundley R, Kugelmass
More informationLeft Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage
Left Internal Mammary Artery to the Left Anterior Descending Artery: Effect on Morbidity and Mortality and Reasons for Nonusage Shishir Karthik, FRCS, Arun K. Srinivasan, FRCS, Antony D. Grayson, BS, Mark
More informationCoronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid?
Coronary Artery Bypass Grafting in Diabetics: All Arterial or Hybrid? Dr. Daniel Navia M.D. Chief Cardiac Surgery Department ICBA, Buenos Aires Argentina, 2018 No disclosures 2 Current evidence The FREEDOM
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationThe development of cardiogenic shock portends an extremely poor prognosis. Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction
TREATMENT UPDATE Cardiogenic Shock: A Lethal Complication of Acute Myocardial Infarction David R. Holmes, Jr, MD Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN Cardiogenic shock is a serious
More informationCoronary Artery Disease: Revascularization (Teacher s Guide)
Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationI t is becoming increasingly clear that inflammation plays a
25 CARDIOVASCULAR MEDICINE Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome L S Rallidis, M G
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationProlonged Oral Morphine Therapy for Severe Angina Pectoris
Vol. 19 No. 5 May 2000 Journal of Pain and Symptom Management 393 Clinical Note Prolonged Oral Morphine Therapy for Severe Angina Pectoris Meir Mouallem, MD, Eli Schwartz, MD, and Zvi Farfel, MD Department
More informationPathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL
Pathology of percutaneous interventions (PCI) in coronary arteries Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL Percutaneous Coronary Intervention (PCI) Definition: transcatheter opening of
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationPreoperative risk factors for carotid endarterectomy: Defining the patient at high risk
Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk Amy B. Reed, MD, a Peter Gaccione, MA, b Michael Belkin, MD, b Magruder C. Donaldson, MD, b John A. Mannick, MD,
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationWhy is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager
Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition
More informationCoronary Artery Stenosis. Insight from MAIN-COMPARE Study
PCI for Unprotected Left Main Coronary Artery Stenosis Insight from MAIN-COMPARE Study Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Asan Medical Center Current Practice
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial
More informationThe Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models
The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models A. Laurie W. Shroyer, PhD, Laura P. Coombs, PhD, Eric D. Peterson, MD, Mary C. Eiken, MSN, Elizabeth R. DeLong, PhD,
More informationCardiac surgery in Victorian public hospitals, Public report
Cardiac surgery in Victorian public hospitals, 2009 10 Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Authors: DT Dinh, L Tran, V Chand, A Newcomb, G Shardey, B Billah
More information